• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Parasitic worms
      • Mycetoma
      • Dengue
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Evidence for impact
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
      • DNDi West and Central Africa
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • Our story
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

African researchers trained on science communication

5 Dec 2022

The COVID-19 pandemic greatly impacted the world and how it responds to emerging health threats. Science communication has emerged as a powerful tool for managing public health. Journalists and health communicators were looking for stories of hope and action and turned to researchers and scientists for this information.

Scientific evidence should inform public decision-making and support access to innovation and tools. In the African continent where some of the most infectious diseases cause untold suffering, it is critical that information about clinical research be shared with non-scientific audiences including policy makers, communities, and civil societies.

In response to this issue, Drugs for Neglected Diseases initiative (DNDi) organized a virtual science communication workshop from the 29 November to 2 December 2022.

Fifteen scientists, researchers, and programme managers from nine African countries attended the workshop which was geared towards equipping them with skills to communicate about their work. The participants were drawn from countries where the ANTICOV clinical trial is being conducted to find a treatment for mild to moderate COVID-19.

The workshop was facilitated by the Training Centre in Communication, an African-based training centre that teaches effective communication skills to scientists.

The areas of discussion at the workshop included messaging, working with the media, persuasive writing (including development of opinion pieces), and using social media as a platform for science communication.

Guest speakers from the media were invited to the workshop including a health journalist who took the participants through a practical session about responding to journalists during an interview. The Conversation Africa editors were also present to encourage the scientists to submit opinion pieces about important topics. Four out of the fifteen participants from the workshop went through more specialized mentoring and have submitted opinion editorials for publishing.

This workshop is part of DNDi’s efforts to strengthen capacities of both journalists and scientists to communicate effectively about research. DNDi has already conducted three media workshops for health and science reporters from Africa and Asia to help reporters better understand complex science. Building the capacity of scientists will help grow the number of expert sources for their articles and bridge the gap between these two groups.

Africa

Read, watch, share

Loading...
Hand with lap glove holding a sample with transparent liquid
Publications
8 Sep 2026

Implementing Article 9.5 of the WHO Pandemic Agreement

Stories
27 Aug 2026

Drug discovery explained: Moonshot: open science to prepare for pandemics?

Pictures of patients waiting at the Mycetoma Research Center in Sudan
Stories
20 Aug 2026

Mycetoma at 10: What recognition made possible

Nature Africa logo
Viewpoints
3 Aug 2026

A new chapter for African medical innovation

Nature Africa
Viewpoints
30 Jul 2026

Ten years after WHO recognition, mycetoma remains one of the world’s most neglected diseases

Stat News
Leishmaniasis patient Monica Lomoler carrying a bunch of firewood
Press releases
29 Jul 2026

WHO recommends new, better and safer treatment regimens for leishmaniasis

Press releases
27 Jul 2026

DNDi leadership to change in 2027

Stories
16 Jul 2026

Annie Liang: How students’ advocacy helped bring mycetoma out of the shadows

VIEW ALL

Help neglected patients

To date, we have delivered seventeen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Youtube Tiktok Facebook-f
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films, and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International license